Research and Development

New Jersey-based biotech firm Amicus Therapeutics has been forced to terminate its development of its candidate for treating rare skin …

The collaborative efforts of Domainex and Auspherix have made new progress in the development of a solution to the growing …

Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …

At the European Academy of Dermatology and Venereology Congress in Geneva, Switzerland, Novartis unveiled new Phase 3 data for Cosentyx …

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …

AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add …

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …

Following Deloitte’s anaylsis of the return on R&D spend by biopharmaceutical companies, this report reveals the key difficulties faced, as …